Ethical issues with implantable defibrillators

PACE - Pacing and Clinical Electrophysiology

Volumn 27, Issue 7, 2004, Pages 897-898

  Brennan, F James ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; MORTALITY; PROGNOSIS; RISK REDUCTION; SHORT SURVEY; SUDDEN DEATH; TREATMENT OUTCOME;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SURVIVORS; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 3242771364     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2004.00554.x     Document Type: Short Survey

References (13)

1. Prystowsky EN. Primary and secondary prevention of sudden cardiac death: The role of the implantable cardioverter defibrillator. Rev Cardiovasc Med 2001; 2:197-205.
2. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583.
3. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102:748-754.
4. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable defibrillator against amiodarone. Circulation 2000; 101:1297-1302.
5. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335:1933-1940.
6. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 2000; 342:1882-1890.
7. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346:877-883.
8. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002; 106:2145-2161.
9. Hux JE, Levinton CM, Naylor CD. Prescribing propensity: Influence of life-expectancy gains and drug costs. J Gen Intern Med 1994; 9:195-201.
10. Canadian Medical Association. Code of Ethics. 1996. Article 14. Available at: http://www.cma.ca. Accessed March 17, 2003.
11. Bigger JT, Fleiss JL, Kleiger R, et al. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69:250-258.
12. Hohnloser LH, Ikeda T, Bloomfield DM, et al. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 2003; 362:125-126.
13. Passamini E. Clinical trials - Are they ethical? N Engl J Med 1991; 324:1589-1591.